Interstitial lung disease in children older than 2 years

Pediatric, Allergy, Immunology, and Pulmonology

Volumn 23, Issue 1, 2010, Pages 33-41

  Vece, Timothy J ^a   Fan, Leland L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; TACROLIMUS;

ACUTE LUPUS PNEUMONITIS; ALLERGIC PNEUMONITIS; ANAMNESIS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHILDHOOD DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DRUG MEGADOSE; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; LUNG LAVAGE; LUNG TRANSPLANTATION; PHYSICAL EXAMINATION; POLYMYOSITIS; PRIORITY JOURNAL; PULMONARY CAPILLARITIS; REVIEW; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

EID: 78049387252     PISSN: 2151321X     EISSN: 21513228     Source Type: Journal    
DOI: 10.1089/ped.2010.0008     Document Type: Review

References (56)

1. Fan LL, Deterding RR, Langston C, Pediatric interstitial lung disease revisited, Pediatr Pulmonol 2004; 38: 369-378.
2. Deutsch GH, Young LR, Deterding RR, Fan LL, Dell SD, Bean JA, Brody AS, Nogee LM, Trapnell BC, Langston C, Albright EA, Askin FB, Baker P, Chou PM, Cool CM, Coventry SC, Cutz E, Davis MM, Dishop MK, Galambos C, Patterson K, Travis WD, Wert SE, White FV; Pathology Cooperative Group; ChILD Research Co-operative, Diffuse lung disease in young children: application of a novel classifi cation scheme, Am J Respir Crit Care Med 2007; 176: 1120-1128.
3. Deterding RR. Infants and young children with children's interstitial lung disease. Pediatric Allergy, Immunology, and Pulmonology 2010; 23:25-31.
4. Guillerman RP. Imaging of childhood interstitial lung disease. Pediatric Allergy, Immunology, and Pulmonology 2010; 23:43-68.
5. Dishop MK. Diagnostic pathology of diffuse lung disease in children. Pediatric Allergy, Immunology, and Pulmonology 2010; 23:69-85
6. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classifi cation of the Idiopathic Interstitial Pneumonias, This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001, Am J Respir Crit Care Med 2002; 165: 277-304.
7. Young LR, Nogee LM, Barnett B, Panos RJ, Colby TV, Deutsch GH, Usual interstitial pneumonia in an adolescent with ABCA3 mutations, Chest 2008; 134: 192-195.
8. Nicholson AG, Kim H, Corrin B, Bush A, du Bois RM, Rosenthal M, Sheppard MN, The value of classifying interstitial pneumonitis in childhood according to defi ned histological patterns, Histopathology 1998; 33: 203-211.
9. Kwon SY, Kim JM, Sohn MH, Kim DS, Kim MJ, Cho SH, Acute interstitial pneumonia in siblings: a case report, J Korean Med Sci 2008; 23: 529-532.
10. Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, Sockrider MM, Fan LL, Clinical, radiological and pathological features of ABCA3 mutations in children, Thorax 2008; 63: 366-373.
11. Crestani B, The respiratory system in connective tissue disorders. Allergy 2005; 60: 715-734.
12. Antoniou KM, Margaritopoulos G, Economidou F, Siafakas NM, Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement, Eur Respir J 2009; 33: 882-896.
13. Misra R, Singh G, Aggarwal P, Aggarwal A, Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia, Clin Rheumatol 2007; 26: 1259-1262.
14. Seely JM, Jones LT, Wallace C, Sherry D, Effmann EL, Systemic sclerosis: using high-resolution CT to detect lung disease in children, AJR Am J Roentgenol 1998; 170: 691-697.
15. Desai SR, Veeraraghavan S, Hansell DM, Nikolakopolou A, Goh NS, Nicholson AG, Colby TV, Denton CP, Black CM, du Bois RM, Wells AU, CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fi brosis and nonspecifi c interstitial pneumonia, Radiology 2004; 232: 560-567.
16. Veselý R, Vargová V, Ravelli A, Massa M, Oleksák E, D'Alterio R, Martini A, De Benedetti F, Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis. J Rheumatol 2004; 31: 795-800.
17. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfi eld N, Metersky M; Scleroderma Lung Study Research Group, Cyclophosphamide versus placebo in scleroderma lung disease, N Engl J Med 2006; 354: 2655-2666.
18. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfi eld N, Metersky M, Khanna D, Li N, Li G; Scleroderma Lung Study Research Group, Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease, Am J Respir Crit Care Med 2007; 176: 1026-1034.
19. Kowal-Bielecka O, Landewé R, Avouac J, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Co-Authors, EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR), Ann Rheum Dis 2009; 68: 620-628.
20. Chiu SK, Yang YH, Wang LC, Chiang BL, Ten-year experience of juvenile dermatomyositis: a retrospective study, J Microbiol Immunol Infect 2007; 40: 68-73.
21. Constantin T, Ponyi A, Orbán I, Molnár K, Dérfalvi B, Dicso F, Kálovics T, Müller J, Garami M, Sallai A, Balogh Z, Szalai Z, Fekete G, Dankó K, National registry of patients with juvenile idiopathic infl ammatory myopathies in Hungary\clinical characteristics and disease course of 44 patients with juvenile dermatomyositis, Autoimmunity 2006; 39: 223-232.
22. Kobayashi I, Yamada M, Takahashi Y, Kawamura N, Okano M, Sakiyama Y, Kobayashi K, Interstitial lung disease associated with juvenile dermatomyositis: clinical features and effi cacy of cyclosporin A, Rheumatology (Oxford) 2003; 42: 371-374.
23. Lamblin C, Bergoin C, Saelens T, Wallaert B, Interstitial lung diseases in collagen vascular diseases, Eur Respir J Suppl 2001; 32: 69s-80s
24. Woodhead F, Wells AU, Desai SR, Pulmonary complications of connective tissue diseases, Clin Chest Med 2008; 29: 149-164, vii
25. Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR, Interstitial lung disease in primary Sjögren's syndrome. clinical-pathological evaluation and response to treatment, Am J Respir Crit Care Med 1996; 154: 794-799.
26. Susarla SC, Fan LL, Diffuse alveolar hemorrhage syndromes in children, Curr Opin Pediatr 2007; 19: 314-320.
27. Godfrey S, Pulmonary hemorrhage/hemoptysis in children, Pediatr Pulmonol 2004; 37: 476-484.
28. Nuesslein TG, Teig N, Rieger CH, Pulmonary haemosiderosis in infants and children, Paediatr Respir Rev 2006; 7: 45-48.
29. Yu F, Huang JP, Zou WZ, Zhao MH, The clinical features of anti-neutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese children, Pediatr Nephrol 2006; 21: 497-502.
30. Fullmer JJ, Langston C, Dishop MK, Fan LL, Pulmonary capillaritis in children: a review of eight cases with comparison to other alveolar hemorrhage syndromes, J Pediatr 2005; 146: 376-381.
31. Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L; French Vasculitis Study Group, Azathioprine or methotrexate maintenance for ANCA-associated vasculitis, N Engl J Med 2008; 359: 2790-2803.
32. Boyer D, Westra SJ, Kinane TB, Stone JR, Case records of the Massachusetts General Hospital. Case 3-2007. A 3-year-old boy with recurrent episodes of respiratory insuffi ciency, N Engl J Med 2007; 356: 398-407.
33. Luo XQ, Ke ZY, Huang LB, Guan XQ, Zhang XL, Zhu J, Zhang YC, Maintenance therapy with dose-adjusted 6-mercaptopurine in idiopathic pulmonary hemosiderosis, Pediatr Pulmonol 2008; 43: 1067-1071.
34. Fan LL, Hypersensitivity pneumonitis in children, Curr Opin Pediatr 2002; 14: 323-326.
35. Patel AM, Ryu JH, Reed CE, Hypersensitivity pneumonitis: current concepts and future questions, J Allergy Clin Immunol 2001; 108: 661-670.
36. Venkatesh P, Wild L, Hypersensitivity pneumonitis in children: clinical features, diagnosis, and treatment, Paediatr Drugs 2005; 7: 235-244.
37. Farber HJ, Paulose Varghese N, Hilman BC. Hypersensitivity pneumonitis, Available at http://emedicine.medscape.com/article/1005107-overview.
38. Olesen HV, Thelle T, Møller JC, Childhood hypersensitivity pneumonitis probably caused by cat hair, Acta Paediatr 1998; 87: 811-813.
39. Cormier Y, Létourneau L, Racine G, Signifi cance of precipitins and asymptomatic lymphocytic alveolitis: a 20-yr follow-up, Eur Respir J 2004; 23: 523-525.
40. Korosec P, Osolnik K, Kern I, Silar M, Mohorcic K, Kosnik M, Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis, Chest 2007; 132: 1291-1297.
41. Fink JN, Ortega HG, Reynolds HY, Cormier YF, Fan LL, Franks TJ, Kreiss K, Kunkel S, Lynch D, Quirce S, Rose C, Schleimer RP, Schuyler MR, Selman M, Trout D, Yoshizawa Y, Needs and opportunities for research in hypersensitivity pneumonitis, Am J Respir Crit Care Med 2005; 171: 792-798.
42. Denis M, Proinfl ammatory cytokines in hypersensitivity pneumonitis. Am J Respir Crit Care Med 1995; 151: 164-169.
43. Mroz RM, Korniluk M, Stasiak-Barmuta A, Chyczewska E, Upregulation of Th1 cytokine profi le in bronchoalveolar lavage fl uid of patients with hypersensitivity pneumonitis, J Physiol Pharmacol 2008; 59(Suppl. 6): 499-505.
44. Ye Q, Nakamura S, Sarria R, Costabel U, Guzman J, Interleukin 12, interleukin 18, and tumor necrosis factor alpha release by alveolar macrophages: acute and chronic hypersensitivity pneumonitis, Ann Allergy Asthma Immunol 2009; 102: 149-154.
45. Churg A, Muller NL, Flint J, Wright JL, Chronic hypersensitivity pneumonitis, Am J Surg Pathol 2006; 30: 201-208.
46. Fenoglio CM, Reboux G, Sudre B, Mercier M, Roussel S, Cordier JF, Piarroux R, Dalphin JC, Diagnostic value of serum precipitins to mould antigens in active hypersensitivity pneumonitis, Eur Respir J 2007; 29: 706-712.
47. Patterson R, Greenberger PA, Castile RG, Yee WF, Roberts M, Diagnostic problems in hypersensitivity lung disease, Allergy Proc 1989; 10: 141-147.
48. Dodge RR, Reed CE, Barbee RA, The absence of a relationship between serum precipitins and pulmonary disease in a community. Chest 1978; 73: 608-612.
49. Ratjen F, Costabel U, Griese M, Paul K, Bronchoalveolar lavage fl uid fi ndings in children with hypersensitivity pneumonitis, Eur Respir J 2003; 21: 144-148.
50. Ratjen F, Bredendiek M, Zheng L, Brendel M, Costabel U, Lymphocyte subsets in bronchoalveolar lavage fl uid of children without bronchopulmonary disease, Am J Respir Crit Care Med 1995; 152: 174-178.
51. Riedler J, Grigg J, Stone C, Tauro G, Robertson CF, Bronchoalveolar lavage cellularity in healthy children, Am J Respir Crit Care Med 1995; 152: 163-168.
52. Vergesslich KA, Götz M, Kraft D, [Bird breeder's lung with conversion to fatal fi brosing alveolitis], Dtsch Med Wochenschr 1983; 108: 1238-1242.
53. Fan LL, Kozinetz CA, Factors infl uencing survival in children with chronic interstitial lung disease, Am J Respir Crit Care Med 1997; 156: 939-942.
54. de Blic J, Pulmonary alveolar proteinosis in children, Paediatr Respir Rev 2004; 5: 316-322.
55. Yamamoto H, Yamaguchi E, Agata H, Kandatsu N, Komatsu T, Kawai S, Baba K, Awaya T, Nishikomori R, Tsurusawa M, Nakata K, A combination therapy of whole lung lavage and GM-CSF inhalation in pulmonary alveolar proteinosis, Pediatr Pulmonol 2008; 43: 828-830.
56. White CW, Sondheimer HM, Crouch EC, Wilson H, Fan LL, Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a, N Engl J Med 1989; 320: 1197-1200